Biotechnology
MethylGene Inc. today announced that Donald F. Corcoran, President and Chief Executive Officer of MethylGene, will present at A.G. Edwards' 2nd Annual Emerging Growth Conference in New York City on Wednesday, September 19, 2007 at 9:30 a.m., ET. Mr. Corc
02:34 Sep 12, 2007
MethylGene Inc. annonce aujourd'hui que M. Donald F. Corcoran, président et chef de la direction de MethylGene, présentera au Forum 'A.G. Edwards' 2nd Annual Emerging Growth Conference' à New York mercredi, le 19 septembre 2007 à 9h30 HE. M. Corcoran
02:34 Sep 12, 2007
MethylGene Inc. today announced that Donald F. Corcoran, President and Chief Executive Officer of MethylGene, will present at A.G. Edwards' 2nd Annual Emerging Growth Conference in New York City on Wednesday, September 19, 2007 at 9:30 a.m., ET. Mr. Corc
02:30 Sep 12, 2007
Acceleware Corp. , a leading developer of high-performance computing applications, today announced that Steven Joachims has joined the organization as Vice President of Business Development. Joachims will be responsible for advancing strategic alliances
02:04 Sep 12, 2007
Pharmaceutical intelligence leader Cutting Edge Information is happy to announce a free whitepaper positioned to help pharmaceutical leaders optimize customer relationship management techniques and strategies. The whitepaper is titled 'Pharmaceutical Cus
01:26 Sep 12, 2007
ProMetic Life Sciences Inc. announces the expansion of its clinical program for its orally active drug PBI-1402 for the treatment of anemia in patients with myelodysplastic syndrome , a condition often referred to as 'pre-leukemia' and diagnosed in 25,00
01:04 Sep 12, 2007
ProMetic Sciences de la Vie inc. annonce la progression de son programme clinique pour le PBI-1402, un médicament administré par voie orale, dans le traitement de l'anémie chez les patients atteints de syndromes myélodysplasiques, un état souvent dÃ
01:04 Sep 12, 2007
ProMetic Life Sciences Inc. announces the expansion of its clinical program for its orally active drug PBI-1402 for the treatment of anemia in patients with myelodysplastic syndrome , a condition often referred to as 'pre-leukemia' and diagnosed in 25,00
01:00 Sep 12, 2007
ClinPhone, the global leader in clinical technology solutions, has been appointed as the preferred supplier of randomization and trial supply management services by the Japanese affiliate of leading pharmaceutical company, Bayer. ClinPhone won this major
00:02 Sep 12, 2007
Takeda Pharmaceuticals North America, Inc. is aware of the review of ACTOS® data conducted by A. Michael Lincoff, M.D., and colleagues at the Cleveland Clinic, published in the Journal of the American Medical Association which concluded that ACTOS i
11:48 Sep 11, 2007
VIVALIS and INNATE PHARMA announce today having launched a scientific collaboration to evaluate VIVALIS EBx® cell lines, derived from avian embryonic stem cells, for the production of monoclonal antibodies. The first concrete results prove once agai
11:18 Sep 11, 2007
Each year, in the United States alone, it is estimated that one in every 3,000 people sustains a ruptured or torn anterior cruciate ligament due to trauma or sporting injuries. For most patients, the pain is excruciating and the road to recovery is long.
09:22 Sep 11, 2007
Leading logic nonvolatile memory intellectual property supplier, Impinj, Inc., today announced that the company's customers have shipped more than 600 million chips containing Impinj's AEON NVM cores since 2003.
08:41 Sep 11, 2007
Not for Distribution in the United States or Through U.S. Newswire Services.
07:04 Sep 11, 2007
Ne pas distribuer aux Etats-Unis ou aux agences de transmission américaines
07:04 Sep 11, 2007
35447 - 35461 of 44966 Stories
<<
<
Next 15 Biotechnology
>
>>
Search News
Daily News
